Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Defiance Silver Corp. Regulatory Filings 2020

Sep 21, 2020

46250_rns_2020-09-21_b2907fad-eebb-4791-ac84-8227cc8ffaf9.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

FORM 51-102F3 Material Change Report Section 7.1 of National Instrument 51-102 Continuous Disclosure Obligations

Item 1.Item 2.Item 3.Item 4.Item 5.Item 6.Item 7.Item 8.Item 9. Name and Address of CompanyElysee Development Corp.9thFloor - 1021 West Hastings StreetVancouver, B.C. V6E 0C3 Date of Material ChangeSeptember 18, 2020News ReleaseThe news release was disseminated on September 18, 2020 through the facilities of Stockwatchand Market News and was SEDAR filed with the securities commissions of Alberta and BritishColumbia.Summary of Material ChangeOn September 18, 2020 Elysee Development Corp. announced it has agreed, subject to regulatoryapproval, to grant incentive stock options to directors, officers and consultants on 600,000 commonshares at an exercise price of $0.42 per share for a period of up to five years from the date of grant.Full Description of Material ChangeOn September 18, 2020 Elysee Development Corp. announced it has agreed, subject to regulatoryapproval, to grant incentive stock options to directors, officers and consultants on 600,000 commonshares at an exercise price of $0.42 per share for a period of up to five years from the date of grant.Reliance on subsection 7.1(2) or (3) of National Instrument 51-102N/AOmitted InformationN/AExecutive OfficerGuido CloetensTelephone: (778) 373-1562Date of ReportSeptember 18, 2020

Caution Regarding Forward-Looking Statements

This news release contains certain forward-looking statements that are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements. The Company does not undertake to update any forward-looking statements, oral or written, made by itself or on its behalf, except as required by applicable law.